Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Disease Undergoing PCI

Sponsor
Assiut University (Other)
Overall Status
Unknown status
CT.gov ID
NCT03911895
Collaborator
(none)
1
1
15
0.1

Study Details

Study Description

Brief Summary

Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI

Condition or Disease Intervention/Treatment Phase
  • Device: Stent more than 26 mn length
  • Device: Stent equal to or less than26 mn length

Detailed Description

Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI. The investigators will follow up patient clinically and use lab investigation.

Study Design

Study Type:
Observational
Anticipated Enrollment :
1 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Impact of Stent Length on Short Term Outcomes in Patients With Stable Coronary Artery Disease Undergoing PCI
Anticipated Study Start Date :
Jul 1, 2019
Anticipated Primary Completion Date :
Jun 30, 2020
Anticipated Study Completion Date :
Sep 30, 2020

Arms and Interventions

Arm Intervention/Treatment
patients with coronary artery diseas undergoing PCI

Effect of stent length on patients with coronary artery undergoing PCI

Device: Stent more than 26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)

Device: Stent equal to or less than26 mn length
stent length in patients undergoing PCI (Drug Eluting Stent)

Outcome Measures

Primary Outcome Measures

  1. Impact of stent length on short term outcomes in patients with stable coronary artery disease undergoing PCI [3 months]

    to study effect of stent length in patients undergoing PCI

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 80 Years
Sexes Eligible for Study:
All
Inclusion Criteria:
  • patient was CAD referred for elective PC as single vessel
Exclusion Criteria:
  • patients admitted ACS patients with primary PCI PTCA without stenting No complete revascularization PCI-related coronary complication (diessaction,no really)

Contacts and Locations

Locations

Site City State Country Postal Code
1 Mohamed abdelbast Assiut Egypt 23123

Sponsors and Collaborators

  • Assiut University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Mohamed Abd elbaset Hassan, Principal investigator, Assiut University
ClinicalTrials.gov Identifier:
NCT03911895
Other Study ID Numbers:
  • Stent length impact on PCI
First Posted:
Apr 11, 2019
Last Update Posted:
Apr 11, 2019
Last Verified:
Mar 1, 2019
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 11, 2019